Loading...
Loading...
Among the 8 tracked institutional investors we monitor, ARQT (ARCUTIS BIOTHERAPEUTICS INC) is held with a combined value of $610.11M across 24,208,695 shares. The largest holder is BlackRock, Inc. with a position worth $216.76M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$610.11M
Total Shares Held
24,208,695
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $216.76M | 0.00% | +1.1% |
| 2 | VANGUARD GROUP INC | $210.65M | 0.00% | New |
| 3 | STATE STREET CORP | $148.34M | 0.01% | +14.7% |
| 4 | Point72 Asset Management, L.P. | $13.92M | 0.02% | +39.0% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $10.39M | 0.02% | +60.9% |
| 6 | FMR LLC | $6.57M | 0.00% | +35.7% |
| 7 | CITADEL ADVISORS LLC | $2.31M | 0.00% | -67.4% |
| 8 | MILLENNIUM MANAGEMENT LLC | $1.16M | 0.00% | -79.2% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ARQT with a position worth $216.76M, representing 0.00% of their portfolio. In total, 8 institutional investors hold ARQT with a combined value of $610.11M.
In the most recent quarter, 1 fund opened a new position in ARQT. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $610.11M worth of ARQT stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $216.76M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ARQT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ARQT positions.